AXGT - Axovant Gene Therapies Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts6566
Avg. Estimate-0.22-0.21-1.19-0.86
Low Estimate-0.28-0.29-1.25-1.25
High Estimate-0.16-0.15-1.12-0.64
Year Ago EPS-0.23-0.48-2.06-1.19
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts6566
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-0.36-0.18-0.37-0.26
EPS Actual-0.23-0.48-0.28-0.27
Difference0.13-0.30.09-0.01
Surprise %36.10%-166.70%24.30%-3.80%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.22-0.21-1.19-0.86
7 Days Ago-0.23-0.21-1.21-0.94
30 Days Ago-0.24-0.22-1.13-0.95
60 Days Ago-0.26-0.16-1.15-1.01
90 Days Ago-0.25-0.16-1.23-1.02
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1N/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesAXGTIndustrySectorS&P 500
Current Qtr.4.30%N/AN/A-0.02
Next Qtr.56.30%N/AN/A0.04
Current Year42.20%N/AN/A0.05
Next Year27.70%N/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A